Search

Search Constraints

You searched for: Author/Creator Onar-Thomas, Arzu

Search Results

1. 13: Photon Versus Proton Whole Ventricular Radiotherapy for Intracranial Non-Germinomatous Germ Cell Tumours - A Report from the Children's Oncology Group. (September 2022)

2. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Issue 6 (3rd February 2020)

3. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Issue 10 (25th February 2021)

4. ATRT-22. Outcomes for children with recurrent atypical teratoid rhabdoid tumor: A single institution study with updated molecular and germline analysis. (3rd June 2022)

5. BIOM-36. SERIAL ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN MEDULLOBLASTOMA LIQUID BIOPSIES. (12th November 2021)

6. Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study. Issue 9 (5th April 2021)

7. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. Issue 7 (1st March 2021)

8. Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Issue 8 (21st March 2022)

9. CRAN-21. PHASE II STUDY OF PEGINTERFERON ALFA-2b (PEGINTRON)/SYLATRON FOR PEDIATRIC PATIENTS WITH PROGRESSIVE OR RECURRENT CRANIOPHARYNGIOMA FOLLOWING RADIOTHERAPY: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-039). Issue 2 (22nd June 2018)

10. CRAN-21. PHASE II STUDY OF PEGINTERFERON ALFA-2b (PEGINTRON)/SYLATRON FOR PEDIATRIC PATIENTS WITH PROGRESSIVE OR RECURRENT CRANIOPHARYNGIOMA FOLLOWING RADIOTHERAPY: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-039). Issue 2 (22nd June 2018)